Shopping Cart 0
Cart Subtotal
USD 0

Ophthalmology Drugs MGR 2017

Bundle Purchase

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 4000

Access to Printed Report; No Soft Copy
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : Printed Publication/ Book by Post

Hard Copy License
USD 4000

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 6000

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

CD-Rom
USD 4000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 8000

Details

Ophthalmology drugs market covers drugs that are used in the treatment of eye related diseases such as refractive errors, cataracts, glaucoma, conjunctivitis, retinal diseases, and macular degeneration. Some of the major drugs include Eylea, Lucentis, Restasis, Vigamox, Azopt, and Lotemax.

The global ophthalmology drugs market was estimated to be around $26 billion as of 2016. The ophthalmology drugs market market made up around 2.5% of the overall pharmaceuticals market in 2016. The ophthalmology drugs market was the smallest market in the global pharmaceutical market in 2016.

Development Of Combination Therapies

Development of combination therapies for the treatment of eye related diseases including glaucoma is an emerging trend in the market. For instance, in September 2013, Alcon (a subsidiary of Novartis) received FDA approval for commercialization of its Simbrinza, a fixed dose combination drug without beta blocker used for the treatment of glaucoma.

The Ophthalmology Drugs Market Global Report provides strategists, marketers and senior management with the critical information they need to assess the global ophthalmology drugs sector.

Reasons to Purchase

Outperform competitors using accurate up to date demand-side dynamics information.

Identify growth segments for investment.

Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.

Create regional and country strategies on the basis of local data and analysis.

Stay abreast of the latest customer and market research findings

Benchmark performance against key competitors.

Develop strategies based on likely future developments.

Utilize the relationships between key data sets for superior strategizing.

Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Gain a global perspective on the development of the market.

Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the ophthalmology drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ophthalmology drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider pharmaceutical drugs market, and compares it with other markets.

The market characteristics section of the report defines and explains the market.

The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

Market segmentations break down market into sub markets.

The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.

Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.

The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.

The ophthalmology drugs market section of the report gives context. It compares the ophthalmology drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The Ophthalmology Drugs Indicators Comparison.

The industry metrics section looks at critical drivers including patient numbers (epidemiology) hospital beds and specialist physicians while the macro-economic section looks at the market in relation to the overall economy.

Scope

Markets Covered: Glaucoma, Dry Eye, Others (Retinal Disorders, Anti-Infectives/Allergy)

Companies Mentioned: Novartis AG, Regeneron, Allergan, F. Hoffmann-La Roche Ltd, and Pfizer Inc.

Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Ophthalmology Drugs Indicators Comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

READ MORE

Table Of Content

Scope

1. Ophthalmology Drugs Market Characteristics;

2. Ophthalmology Drugs Market Size And Growth;

2.1. Historic Market Growth; 2.1.1. Drivers Of The Market; 2.1.2. Restraints On The Market; 2.2. Forecast Market Growth; 2.2.1. Drivers Of The Market; 2.2.2. Restraints On The Market;

3. Pestle Analysis;

3.1. Political; 3.2. Economic; 3.3. Social; 3.4. Technological; 3.5. Legal; 3.6. Environmental;

4. Ophthalmology Drugs Market Customer Information;

5. Ophthalmology Drugs Market Segmentation;

5.1. Global Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 5.2. Global Ophthalmology Drugs Market, 2012-2020, Historic And Forecast, By Segment; 5.3 Global Ophthalmology Drugs Market Trends And Strategies;

6. Ophthalmology Drugs Market Regional And Country Analysis;

6.1. Global Ophthalmology Drugs Market, 2016, By Region; 6.2. Global Ophthalmology Drugs Market, 2012-2020, Historic And Forecast, By Region; 6.3. Ophthalmology Drugs Market, 2016, By Country; 6.4. Ophthalmology Drugs Market, 2012-2020, Historic And Forecast, By Country; 6.5. Global Pharmaceutical Market Segments, 2016, By Region; 6.6. Global Pharmaceutical Drugs Market Segments, 2016, By Region; 6.7. Global Pharmaceutical Market Segments, 2016, By Country; 6.8. Global Pharmaceutical Drugs Market Segments, 2016, By Country;

7. Global Ophthalmology Drugs Market Comparison With Macro Economic Factors;

7.1. Ophthalmology Drugs Market Size, Percentage Of GDP, Global; 7.2. Per Capita Average Ophthalmology Drugs Expenditure, Global;

8. Ophthalmology Drugs Market Comparison With Macro Economic Factors Across Countries;

8.1. Ophthalmology Drugs Market Size, Percentage Of GDP, By Country; 8.2. Per Capita Average Ophthalmology Drugs Expenditure, By Country;

9. Ophthalmology Drugs Market Comparison With Industry Metrics;

9.1. Global Number Of Pharmacists, 2016, By Country; 9.2. Global Ophthalmology Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country; 9.3. Global Number Of Pharma Enterprises, 2016, By Country; 9.4. Global Ophthalmology Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country; 9.5. Global Average Spending On R&D/Product Development, 2016, By Country; 9.6. Global Ophthalmology Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country; 9.7. Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.8. Global Ophthalmology Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.9. Prevalent Cases Of Glaucoma, 2014, By Country;

10. Asia-Pacific Ophthalmology Drugs Market;

10.1.1. Asia-Pacific Ophthalmology Drugs Market Overview; 10.1.2. Asia-Pacific Ophthalmology Drugs Historic Market, 2012-2016; 10.1.3. Asia-Pacific Ophthalmology Drugs Forecast Market, 2016-2020; 10.1.4. Asia-Pacific Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 10.2. Asia-Pacific Ophthalmology Drugs Market: Country Analysis; 10.3. China Ophthalmology Drugs Market; 10.3.1. China Ophthalmology Drugs Market Overview; 10.3.2. China Ophthalmology Drugs Historic Market, 2012-2016; 10.3.3. China Ophthalmology Drugs Forecast Market, 2016-2020; 10.3.4. China Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 10.3.5. China Ophthalmology Drugs Percentage Of GDP, 2012-2020; 10.3.6. China Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020; 10.4. India Ophthalmology Drugs Market; 10.4.1. India Ophthalmology Drugs Market Overview; 10.4.2. India Ophthalmology Drugs Historic Market, 2012-2016; 10.4.3. India Ophthalmology Drugs Forecast Market, 2016-2020; 10.4.4. India Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 10.4.5. India Ophthalmology Drugs Percentage Of GDP, 2012-2020; 10.4.6. India Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020; 10.5. Japan Ophthalmology Drugs Market; 10.5.1. Japan Ophthalmology Drugs Market Overview; 10.5.2. Japan Ophthalmology Drugs Historic Market, 2012-2016; 10.5.3. Japan Ophthalmology Drugs Forecast Market, 2016-2020; 10.5.4. Japan Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 10.5.5. Japan Ophthalmology Drugs Percentage Of GDP, 2012-2020; 10.5.6. Japan Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020; 10.6. Australia Ophthalmology Drugs Market; 10.6.1. Australia Ophthalmology Drugs Historic Market, 2012-2016; 10.6.2. Australia Ophthalmology Drugs Forecast Market, 2016-2020; 10.6.3. Australia Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 10.6.4. Australia Ophthalmology Drugs Percentage Of GDP, 2012-2020; 10.6.5. Australia Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020;

11. Western Europe Ophthalmology Drugs Market;

11.1.1. Western Europe Ophthalmology Drugs Market Overview; 11.1.2. Western Europe Ophthalmology Drugs Historic Market, 2012-2016; 11.1.3. Western Europe Ophthalmology Drugs Forecast Market, 2016-2020; 11.1.4. Western Europe Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 11.2. Western Europe Ophthalmology Drugs Market: Country Analysis; 11.3. UK Ophthalmology Drugs Market; 11.3.1. UK Ophthalmology Drugs Market Overview; 11.3.2. UK Ophthalmology Drugs Historic Market, 2012-2016; 11.3.3. UK Ophthalmology Drugs Forecast Market, 2016-2020; 11.3.4. UK Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 11.3.5. UK Ophthalmology Drugs Percentage Of GDP, 2012-2020; 11.3.6. UK Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020; 11.4. Germany Ophthalmology Drugs Market; 11.4.1. Germany Ophthalmology Drugs Historic Market, 2012-2016; 11.4.2. Germany Ophthalmology Drugs Forecast Market, 2016-2020; 11.4.3. Germany Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 11.4.4 Germany Ophthalmology Drugs Percentage Of GDP, 2012-2020; 11.4.5 Germany Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020; 11.5 France Ophthalmology Drugs Market; 11.5.1 France Ophthalmology Drugs Historic Market, 2012-2016; 11.5.2 France Ophthalmology Drugs Forecast Market, 2016-2020; 11.5.3 France Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 11.5.4 France Ophthalmology Drugs Percentage Of GDP, 2012-2020; 11.5.5 France Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020; 11.6. Italy Ophthalmology Drugs Market; 11.6.1. Italy Ophthalmology Drugs Historic Market, 2012-2016; 11.6.2. Italy Ophthalmology Drugs Forecast Market, 2016-2020; 11.6.3. Italy Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 11.6.4. Italy Ophthalmology Drugs Percentage Of GDP, 2012-2020; 11.6.5. Italy Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020; 11.7. Spain Ophthalmology Drugs Market; 11.7.1. Spain Ophthalmology Drugs Historic Market, 2012-2016; 11.7.2. Spain Ophthalmology Drugs Forecast Market, 2016-2020; 11.7.3. Spain Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 11.7.4. Spain Ophthalmology Drugs Percentage Of GDP, 2012-2020; 11.7.5. Spain Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020;

12. Eastern Europe Ophthalmology Drugs Market;

12.1.1. Eastern Europe Ophthalmology Drugs Market Overview; 12.1.2. Eastern Europe Ophthalmology Drugs Historic Market, 2012-2016; 12.1.3. Eastern Europe Ophthalmology Drugs Forecast Market, 2016-2020; 12.1.4 Eastern Europe Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 12.2. Eastern Europe Ophthalmology Drugs Market: Country Analysis; 12.3. Russia Ophthalmology Drugs Market; 12.3.1. Russia Ophthalmology Drugs Historic Market, 2012-2016; 12.3.2. Russia Ophthalmology Drugs Forecast Market, 2016-2020; 12.3.3. Russia Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 12.3.4. Russia Ophthalmology Drugs Percentage Of GDP, 2012-2020; 12.3.5. Russia Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020;

13. North America Ophthalmology Drugs Market;

13.1.1. North America Ophthalmology Drugs Market Overview; 13.1.2. North America Ophthalmology Drugs Historic Market, 2012-2016; 13.1.3. North America Ophthalmology Drugs Forecast Market, 2016-2020; 13.1.4. North America Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 13.2. North America Ophthalmology Drugs Market: Country Analysis; 13.3. USA Ophthalmology Drugs Market; 13.3.1. USA Ophthalmology Drugs Historic Market, 2012-2016; 13.3.2. USA Ophthalmology Drugs Forecast Market, 2016-2020; 13.3.3 USA Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 13.3.4. USA Ophthalmology Drugs Percentage Of GDP, 2012-2020; 13.3.5. USA Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020;

14. South America Ophthalmology Drugs Market;

14.1.1. South America Ophthalmology Drugs Market Overview; 14.1.2. South America Ophthalmology Drugs Historic Market, 2012-2016; 14.1.3. South America Ophthalmology Drugs Forecast Market, 2016-2020; 14.1.4. South America Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 14.2. South America Ophthalmology Drugs Market: Country Analysis; 14.3. Brazil Ophthalmology Drugs Market; 14.3.1. Brazil Ophthalmology Drugs Historic Market, 2012-2016; 14.3.2. Brazil Ophthalmology Drugs Forecast Market, 2016-2020; 14.3.3. Brazil Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 14.3.4. Brazil Ophthalmology Drugs Percentage Of GDP, 2012-2020; 14.3.5. Brazil Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020;

15. Middle East Ophthalmology Drugs Market;

15.1.1. Middle East Ophthalmology Drugs Market Overview; 15.1.2. Middle East Ophthalmology Drugs Historic Market, 2012-2016; 15.1.3. Middle East Ophthalmology Drugs Forecast Market, 2016-2020; 15.1.4. Middle East Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy);

16. Africa Ophthalmology Drugs Market;

16.1.1. Africa Ophthalmology Drugs Market Overview; 16.1.2. Africa Ophthalmology Drugs Historic Market, 2012-2016; 16.1.3. Africa Ophthalmology Drugs Forecast Market, 2016-2020; 16.1.4. Africa Ophthalmology Drugs Market, 2016, By Segment; 16.1.4. Africa Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy);

17. Ophthalmology Drugs Market Competitive Landscape;

17.1. Company Profiles; 17.2. Novartis Ag; 17.2.1. Overview; 17.2.2. Products And Services; 17.2.3. Strategy; 17.2.4. Financial Performance; 17.3. Regeneron; 17.3.1. Overview; 17.3.2. Products And Services; 17.3.3. Strategy; 17.3.4. Financial Performance; 17.4. Allergan; 17.4.1. Overview; 17.4.2. Products And Services; 17.4.3. Strategy; 17.4.4. Financial Performance; 17.5. F. Hoffmann-La Roche Ltd; 17.5.1. Overview; 17.5.2. Products And Services; 17.5.3. Strategy; 17.5.4. Financial Performance; 17.6. Pfizer Inc.; 17.6.1. Overview; 17.6.2. Products And Services; 17.6.3. Strategy; 17.6.4. Financial Performance;

18. Key Mergers And Acquisitions In The Ophthalmology Drugs Market;

19. Market Background: Pharmaceutical Drugs Market;

19.1.1. Pharmaceutical Drugs Market Characteristics; 19.1.2. Pharmaceutical Drugs Market Historic Growth; 19.1.2.1. Drivers Of The Market; 19.1.2.2. Restraints Of The Market; 19.1.3. Pharmaceutical Drugs Market Forecast Growth; 19.1.3.1. Drivers Of The Market; 19.1.3.2. Restraints Of The Market; 19.1.4. Pharmaceutical Drugs Trends And Strategies; 19.2. Pharmaceutical Drugs Market Regional And Country Analysis; 19.2.1. Global Pharmaceutical Drugs Market, 2016, By Region; 19.2.2. Global Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Region; 19.2.3. Pharmaceutical Drugs Market, 2016, By Country; 19.2.4. Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Country; 19.2.5. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Segment; 19.2.6. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Country And Segment; 19.3. Global Pharmaceutical Drugs Market Comparison With Macro Economic Factors; 19.3.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, Global; 19.3.2. Per Capita Average Pharmaceutical Drugs Expenditure, Global; 19.4. Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries; 19.4.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country; 19.4.2. Per Capita Average Pharmaceutical Drugs Expenditure, By Country; 19.5. Key Mergers And Acquisitions In The Pharmaceutical Drugs Market;

20. Pharmaceuticals Industry Financial Margins;

21. Appendix;

21.1. NAICS Definitions Of Industry Covered In This Report; 21.2. Abbreviations; 21.3. Currencies; 21.4. Research Inquiries; 21.5. The Business Research Company; 21.6. Copyright And Disclaimer


List Of Figure

Table 1: Global Ophthalmology Drugs Historic Market Growth

Table 2: Global Ophthalmology Drugs Forecast Market Growth

Table 3: Ophthalmology Drugs Market Segmentation

Table 4: Global Ophthalmology Drugs Market, 2016, By Segment

Table 5: Global Ophthalmology Drugs Market, 2012-2020, Historic And Forecast, By Segment

Table 6: Global Ophthalmology Drugs Market, 2016, By Region

Table 7: Global Ophthalmology Drugs Market, 2012-2020, Historic And Forecast, By Region

Table 8: Ophthalmology Drugs Market, 2016, By Country

Table 9: Ophthalmology Drugs Market, 2012-2020, Historic And Forecast, By Country

Table 10: Global Pharmaceutical Market Segments, 2016, By Region

Table 11: Global Pharmaceutical Drugs Market Segments, 2016, By Region

Table 12: Global Pharmaceutical Market Segments, 2016, By Country

Table 13: Global Pharmaceutical Drugs Market Segments, 2016, By Country

Table 14: Ophthalmology Drugs Market Size, Percentage Of GDP, Global

Table 15: Per Capita Average Ophthalmology Drugs Expenditure, Global

Table 16: Ophthalmology Drugs Market Comparison With Macro Economic Factors Across Countries

Table 17: Ophthalmology Drugs Market Size, Percentage Of GDP, By Country

Table 18: Per Capita Average Ophthalmology Drugs Expenditure, By Country

Table 19: Global Number Of Pharmacists, 2016, By Country

Table 20: Global Ophthalmology Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country

Table 21: Global Number Of Pharma Enterprises, 2016, By Country

Table 22: Global Ophthalmology Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country

Table 23: Global Average Spending On R&D/Product Development, 2016, By Country

Table 24: Global Ophthalmology Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country

Table 25: Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country

Table 26: Global Ophthalmology Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country

Table 27: Prevalent Cases Of Glaucoma, 2014, By Country

Table 28: Asia-Pacific Ophthalmology Drugs Historic Market, 2012-2016

Table 29: Asia-Pacific Ophthalmology Drugs Forecast Market, 2016-2020

Table 30: Asia-Pacific Ophthalmology Drugs Market, 2016, By Segment

Table 31: China Ophthalmology Drugs Historic Market, 2012-2016

Table 32: China Ophthalmology Drugs Forecast Market, 2016-2020

Table 33: China Ophthalmology Drugs Market, 2016, By Segment

Table 34: China Ophthalmology Drugs Percentage Of GDP, 2012-2020

Table 35: China Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020

Table 36: India Ophthalmology Drugs Historic Market, 2012-2016

Table 37: India Ophthalmology Drugs Forecast Market, 2016-2020

Table 38: India Ophthalmology Drugs Market, 2016, By Segment

Table 39: India Ophthalmology Drugs Percentage Of GDP, 2012-2020

Table 40: India Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020

Table 41: Japan Ophthalmology Drugs Historic Market, 2012-2016

Table 42: Japan Ophthalmology Drugs Forecast Market, 2016-2020

Table 43: Japan Ophthalmology Drugs Market, 2016, By Segment

Table 44: Japan Ophthalmology Drugs Percentage Of GDP, 2012-2020

Table 45: Japan Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020

Table 46: Australia Ophthalmology Drugs Historic Market, 2012-2016

Table 47: Australia Ophthalmology Drugs Forecast Market, 2016-2020

Table 48: Australia Ophthalmology Drugs Market, 2016, By Segment

Table 49: Australia Ophthalmology Drugs Percentage Of GDP, 2012-2020

Table 50: Australia Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020

Table 51: Western Europe Ophthalmology Drugs Historic Market, 2012-2016

Table 52: Western Europe Ophthalmology Drugs Forecast Market, 2016-2020

Table 53: Western Europe Ophthalmology Drugs Market, 2016, By Segment

Table 54: UK Ophthalmology Drugs Historic Market, 2012-2016

Table 55: UK Ophthalmology Drugs Forecast Market, 2016-2020

Table 56: UK Ophthalmology Drugs Market, 2016, By Segment

Table 57: UK Ophthalmology Drugs Percentage Of GDP, 2012-2020

Table 58: UK Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020

Table 59: Germany Ophthalmology Drugs Historic Market, 2012-2016

Table 60: Germany Ophthalmology Drugs Forecast Market, 2016-2020

Table 61: Germany Ophthalmology Drugs Market, 2016, By Segment

Table 62: Germany Ophthalmology Drugs Percentage Of GDP, 2012-2020

Table 63: Germany Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020

Table 64: France Ophthalmology Drugs Historic Market, 2012-2016

Table 65: France Ophthalmology Drugs Forecast Market, 2016-2020

Table 66: France Ophthalmology Drugs Market, 2016, By Segment

Table 67: France Ophthalmology Drugs Percentage Of GDP, 2012-2020

Table 68: France Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020

Table 69: Italy Ophthalmology Drugs Historic Market, 2012-2016

Table 70: Italy Ophthalmology Drugs Forecast Market, 2016-2020

Table 71: Italy Ophthalmology Drugs Market, 2016, By Segment

Table 72: Italy Ophthalmology Drugs Percentage Of GDP, 2012-2020

Table 73: Italy Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020

Table 74: Spain Ophthalmology Drugs Historic Market, 2012-2016

Table 75: Spain Ophthalmology Drugs Forecast Market, 2016-2020

Table 76: Spain Ophthalmology Drugs Market, 2016, By Segment

Table 77: Spain Ophthalmology Drugs Percentage Of GDP, 2012-2020

Table 78: Spain Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020

Table 79: Eastern Europe Ophthalmology Drugs Historic Market, 2012-2016

Table 80: Eastern Europe Ophthalmology Drugs Forecast Market, 2016-2020

Table 81: Eastern Europe Ophthalmology Drugs Market, 2016, By Segment

Table 82: Russia Ophthalmology Drugs Historic Market, 2012-2016

Table 83: Russia Ophthalmology Drugs Forecast Market, 2016-2020

Table 84: Russia Ophthalmology Drugs Market, 2016, By Segment

Table 85: Russia Ophthalmology Drugs Percentage Of GDP, 2012-2020

Table 86: Russia Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020

Table 87: North America Ophthalmology Drugs Historic Market, 2012-2016

Table 88: North America Ophthalmology Drugs Forecast Market, 2016-2020

Table 89: North America Ophthalmology Drugs Market, 2016, By Segment

Table 90: USA Ophthalmology Drugs Historic Market, 2012-2016

Table 91: USA Ophthalmology Drugs Forecast Market, 2016-2020

Table 92: USA Ophthalmology Drugs Market, 2016, By Segment

Table 93: USA Ophthalmology Drugs Percentage Of GDP, 2012-2020

Table 94: USA Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020

Table 95: South America Ophthalmology Drugs Historic Market, 2012-2016

Table 96: South America Ophthalmology Drugs Forecast Market, 2016-2020

Table 97: South America Ophthalmology Drugs Market, 2016, By Segment

Table 98: Brazil Ophthalmology Drugs Historic Market, 2012-2016

Table 99: Brazil Ophthalmology Drugs Forecast Market, 2016-2020

Table 100: Brazil Ophthalmology Drugs Market, 2016, By Segment

Table 101: Brazil Ophthalmology Drugs Percentage Of GDP, 2012-2020

Table 102: Brazil Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020

Table 103: Middle East Ophthalmology Drugs Historic Market, 2012-2016

Table 104: Middle East Ophthalmology Drugs Forecast Market, 2016-2020

Table 105: Middle East Ophthalmology Drugs Market, 2016, By Segment

Table 106: Africa Ophthalmology Drugs Historic Market, 2012-2016

Table 107: Africa Ophthalmology Drugs Forecast Market, 2016-2020

Table 108: Africa Ophthalmology Drugs Market, 2016, By Segment

Table 109: Novartis Ag Financial Performance

Table 110: Regeneron Financial Performance

Table 111: Allergan Financial Performance

Table 112: F. Hoffmann-La Roche Ltd Financial Performance

Table 113: Pfizer Inc. Financial Performance

Table 114: Pharmaceutical Drugs Market Historic Growth

Table 115: Pharmaceutical Drugs Market Forecast Growth

Table 116: Global Pharmaceutical Drugs Market, 2016, By Region

Table 117: Global Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Region

Table 118: Pharmaceutical Drugs Market, 2016, By Country

Table 119: Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Country

Table 120: Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Segment

Table 121: Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Country And Segment

Table 122: Pharmaceutical Drugs Market Size, Percentage Of GDP, Global

Table 123: Per Capita Average Pharmaceutical Drugs Expenditure, Global

Table 124: Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries

Table 125: Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country

Table 126: Per Capita Average Pharmaceutical Drugs Expenditure, By Country

Table 127: Pharmaceuticals Industry Financial Margins


List Of Table

Figure 1: Global Ophthalmology Drugs Historic Market Growth

Figure 2: Global Ophthalmology Drugs Forecast Market Growth

Figure 3: Ophthalmology Drugs Market Segmentation

Figure 4: Global Ophthalmology Drugs Market, 2016, By Segment

Figure 5: Global Ophthalmology Drugs Market, 2012-2020, Historic And Forecast, By Segment

Figure 6: Global Ophthalmology Drugs Market, 2016, By Region

Figure 7: Global Ophthalmology Drugs Market, 2012-2020, Historic And Forecast, By Region

Figure 8: Ophthalmology Drugs Market, 2016, By Country

Figure 9: Ophthalmology Drugs Market, 2012-2020, Historic And Forecast, By Country

Figure 10: Global Pharmaceutical Market Segments, 2016, By Region

Figure 11: Global Pharmaceutical Drugs Market Segments, 2016, By Region

Figure 12: Global Pharmaceutical Market Segments, 2016, By Country

Figure 13: Global Pharmaceutical Drugs Market Segments, 2016, By Country

Figure 14: Ophthalmology Drugs Market Size, Percentage Of GDP, Global

Figure 15: Per Capita Average Ophthalmology Drugs Expenditure, Global

Figure 16: Ophthalmology Drugs Market Comparison With Macro Economic Factors Across Countries

Figure 17: Ophthalmology Drugs Market Size, Percentage Of GDP, By Country

Figure 18: Per Capita Average Ophthalmology Drugs Expenditure, By Country

Figure 19: Global Number Of Pharmacists, 2016, By Country

Figure 20: Global Ophthalmology Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country

Figure 21: Global Number Of Pharma Enterprises, 2016, By Country

Figure 22: Global Ophthalmology Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country

Figure 23: Global Average Spending On R&D/Product Development, 2016, By Country

Figure 24: Global Ophthalmology Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country

Figure 25: Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country

Figure 26: Global Ophthalmology Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country

Figure 27: Prevalent Cases Of Glaucoma, 2014, By Country

Figure 28: Asia-Pacific Ophthalmology Drugs Historic Market, 2012-2016

Figure 29: Asia-Pacific Ophthalmology Drugs Forecast Market, 2016-2020

Figure 30: Asia-Pacific Ophthalmology Drugs Market, 2016, By Segment

Figure 31: China Ophthalmology Drugs Historic Market, 2012-2016

Figure 32: China Ophthalmology Drugs Forecast Market, 2016-2020

Figure 33: China Ophthalmology Drugs Market, 2016, By Segment

Figure 34: China Ophthalmology Drugs Percentage Of GDP, 2012-2020

Figure 35: China Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020

Figure 36: India Ophthalmology Drugs Historic Market, 2012-2016

Figure 37: India Ophthalmology Drugs Forecast Market, 2016-2020

Figure 38: India Ophthalmology Drugs Market, 2016, By Segment

Figure 39: India Ophthalmology Drugs Percentage Of GDP, 2012-2020

Figure 40: India Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020

Figure 41: Japan Ophthalmology Drugs Historic Market, 2012-2016

Figure 42: Japan Ophthalmology Drugs Forecast Market, 2016-2020

Figure 43: Japan Ophthalmology Drugs Market, 2016, By Segment

Figure 44: Japan Ophthalmology Drugs Percentage Of GDP, 2012-2020

Figure 45: Japan Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020

Figure 46: Australia Ophthalmology Drugs Historic Market, 2012-2016

Figure 47: Australia Ophthalmology Drugs Forecast Market, 2016-2020

Figure 48: Australia Ophthalmology Drugs Market, 2016, By Segment

Figure 49: Australia Ophthalmology Drugs Percentage Of GDP, 2012-2020

Figure 50: Australia Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020

Figure 51: Western Europe Ophthalmology Drugs Historic Market, 2012-2016

Figure 52: Western Europe Ophthalmology Drugs Forecast Market, 2016-2020

Figure 53: Western Europe Ophthalmology Drugs Market, 2016, By Segment

Figure 54: UK Ophthalmology Drugs Historic Market, 2012-2016

Figure 55: UK Ophthalmology Drugs Forecast Market, 2016-2020

Figure 56: UK Ophthalmology Drugs Market, 2016, By Segment

Figure 57: UK Ophthalmology Drugs Percentage Of GDP, 2012-2020

Figure 58: UK Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020

Figure 59: Germany Ophthalmology Drugs Historic Market, 2012-2016

Figure 60: Germany Ophthalmology Drugs Forecast Market, 2016-2020

Figure 61: Germany Ophthalmology Drugs Market, 2016, By Segment

Figure 62: Germany Ophthalmology Drugs Percentage Of GDP, 2012-2020

Figure 63: Germany Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020

Figure 64: France Ophthalmology Drugs Historic Market, 2012-2016

Figure 65: France Ophthalmology Drugs Forecast Market, 2016-2020

Figure 66: France Ophthalmology Drugs Market, 2016, By Segment

Figure 67: France Ophthalmology Drugs Percentage Of GDP, 2012-2020

Figure 68: France Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020

Figure 69: Italy Ophthalmology Drugs Historic Market, 2012-2016

Figure 70: Italy Ophthalmology Drugs Forecast Market, 2016-2020

Figure 71: Italy Ophthalmology Drugs Market, 2016, By Segment

Figure 72: Italy Ophthalmology Drugs Percentage Of GDP, 2012-2020

Figure 73: Italy Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020

Figure 74: Spain Ophthalmology Drugs Historic Market, 2012-2016

Figure 75: Spain Ophthalmology Drugs Forecast Market, 2016-2020

Figure 76: Spain Ophthalmology Drugs Market, 2016, By Segment

Figure 77: Spain Ophthalmology Drugs Percentage Of GDP, 2012-2020

Figure 78: Spain Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020

Figure 79: Eastern Europe Ophthalmology Drugs Historic Market, 2012-2016

Figure 80: Eastern Europe Ophthalmology Drugs Forecast Market, 2016-2020

Figure 81: Eastern Europe Ophthalmology Drugs Market, 2016, By Segment

Figure 82: Russia Ophthalmology Drugs Historic Market, 2012-2016

Figure 83: Russia Ophthalmology Drugs Forecast Market, 2016-2020

Figure 84: Russia Ophthalmology Drugs Market, 2016, By Segment

Figure 85: Russia Ophthalmology Drugs Percentage Of GDP, 2012-2020

Figure 86: Russia Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020

Figure 87: North America Ophthalmology Drugs Historic Market, 2012-2016

Figure 88: North America Ophthalmology Drugs Forecast Market, 2016-2020

Figure 89: North America Ophthalmology Drugs Market, 2016, By Segment

Figure 90: USA Ophthalmology Drugs Historic Market, 2012-2016

Figure 91: USA Ophthalmology Drugs Forecast Market, 2016-2020

Figure 92: USA Ophthalmology Drugs Market, 2016, By Segment

Figure 93: USA Ophthalmology Drugs Percentage Of GDP, 2012-2020

Figure 94: USA Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020

Figure 95: South America Ophthalmology Drugs Historic Market, 2012-2016

Figure 96: South America Ophthalmology Drugs Forecast Market, 2016-2020

Figure 97: South America Ophthalmology Drugs Market, 2016, By Segment

Figure 98: Brazil Ophthalmology Drugs Historic Market, 2012-2016

Figure 99: Brazil Ophthalmology Drugs Forecast Market, 2016-2020

Figure 100: Brazil Ophthalmology Drugs Market, 2016, By Segment

Figure 101: Brazil Ophthalmology Drugs Percentage Of GDP, 2012-2020

Figure 102: Brazil Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020

Figure 103: Middle East Ophthalmology Drugs Historic Market, 2012-2016

Figure 104: Middle East Ophthalmology Drugs Forecast Market, 2016-2020

Figure 105: Middle East Ophthalmology Drugs Market, 2016, By Segment

Figure 106: Africa Ophthalmology Drugs Historic Market, 2012-2016

Figure 107: Africa Ophthalmology Drugs Forecast Market, 2016-2020

Figure 108: Africa Ophthalmology Drugs Market, 2016, By Segment

Figure 109: Novartis Ag Financial Performance

Figure 110: Regeneron Financial Performance

Figure 111: Allergan Financial Performance

Figure 112: F. Hoffmann-La Roche Ltd Financial Performance

Figure 113: Pfizer Inc. Financial Performance

Figure 114: Pharmaceutical Drugs Market Historic Growth

Figure 115: Pharmaceutical Drugs Market Forecast Growth

Figure 116: Global Pharmaceutical Drugs Market, 2016, By Region

Figure 117: Global Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Region

Figure 118: Pharmaceutical Drugs Market, 2016, By Country

Figure 119: Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Country

Figure 120: Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Segment

Figure 121: Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Country And Segment

Figure 122: Pharmaceutical Drugs Market Size, Percentage Of GDP, Global

Figure 123: Per Capita Average Pharmaceutical Drugs Expenditure, Global

Figure 124: Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries

Figure 125: Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country

Figure 126: Per Capita Average Pharmaceutical Drugs Expenditure, By Country

Figure 127: Pharmaceuticals Industry Financial Margins

Licence Rights

  • Single User License (for access by one person)
  • Site License (for access of one office location of a company)
  • Corporate License (allow access by all staff of the company)

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Antiglaucoma Drugs, Dry Eye Medication, Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy)


Companies

Novartis AG, Regeneron, Allergan, F. Hoffmann-La Roche Ltd, and Pfizer Inc.

Company Profile

Company Profile Title

Ophthalmology drugs market covers drugs that are used in the treatment of eye related diseases such as refractive errors, cataracts, glaucoma, conjunctivitis, retinal diseases, and macular degeneration. Some of the major drugs include Eylea, Lucentis, Restasis, Vigamox, Azopt, and Lotemax.

The global ophthalmology drugs market was estimated to be around $26 billion as of 2016. The ophthalmology drugs market market made up around 2.5% of the overall pharmaceuticals market in 2016. The ophthalmology drugs market was the smallest market in the global pharmaceutical market in 2016.

Development Of Combination Therapies

Development of combination therapies for the treatment of eye related diseases including glaucoma is an emerging trend in the market. For instance, in September 2013, Alcon (a subsidiary of Novartis) received FDA approval for commercialization of its Simbrinza, a fixed dose combination drug without beta blocker used for the treatment of glaucoma.

The Ophthalmology Drugs Market Global Report provides strategists, marketers and senior management with the critical information they need to assess the global ophthalmology drugs sector.

Reasons to Purchase

Outperform competitors using accurate up to date demand-side dynamics information.

Identify growth segments for investment.

Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.

Create regional and country strategies on the basis of local data and analysis.

Stay abreast of the latest customer and market research findings

Benchmark performance against key competitors.

Develop strategies based on likely future developments.

Utilize the relationships between key data sets for superior strategizing.

Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Gain a global perspective on the development of the market.

Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the ophthalmology drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ophthalmology drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider pharmaceutical drugs market, and compares it with other markets.

The market characteristics section of the report defines and explains the market.

The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

Market segmentations break down market into sub markets.

The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.

Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.

The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.

The ophthalmology drugs market section of the report gives context. It compares the ophthalmology drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The Ophthalmology Drugs Indicators Comparison.

The industry metrics section looks at critical drivers including patient numbers (epidemiology) hospital beds and specialist physicians while the macro-economic section looks at the market in relation to the overall economy.

Scope

Markets Covered: Glaucoma, Dry Eye, Others (Retinal Disorders, Anti-Infectives/Allergy)

Companies Mentioned: Novartis AG, Regeneron, Allergan, F. Hoffmann-La Roche Ltd, and Pfizer Inc.

Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Ophthalmology Drugs Indicators Comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

READ MORE

Scope

1. Ophthalmology Drugs Market Characteristics;

2. Ophthalmology Drugs Market Size And Growth;

2.1. Historic Market Growth; 2.1.1. Drivers Of The Market; 2.1.2. Restraints On The Market; 2.2. Forecast Market Growth; 2.2.1. Drivers Of The Market; 2.2.2. Restraints On The Market;

3. Pestle Analysis;

3.1. Political; 3.2. Economic; 3.3. Social; 3.4. Technological; 3.5. Legal; 3.6. Environmental;

4. Ophthalmology Drugs Market Customer Information;

5. Ophthalmology Drugs Market Segmentation;

5.1. Global Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 5.2. Global Ophthalmology Drugs Market, 2012-2020, Historic And Forecast, By Segment; 5.3 Global Ophthalmology Drugs Market Trends And Strategies;

6. Ophthalmology Drugs Market Regional And Country Analysis;

6.1. Global Ophthalmology Drugs Market, 2016, By Region; 6.2. Global Ophthalmology Drugs Market, 2012-2020, Historic And Forecast, By Region; 6.3. Ophthalmology Drugs Market, 2016, By Country; 6.4. Ophthalmology Drugs Market, 2012-2020, Historic And Forecast, By Country; 6.5. Global Pharmaceutical Market Segments, 2016, By Region; 6.6. Global Pharmaceutical Drugs Market Segments, 2016, By Region; 6.7. Global Pharmaceutical Market Segments, 2016, By Country; 6.8. Global Pharmaceutical Drugs Market Segments, 2016, By Country;

7. Global Ophthalmology Drugs Market Comparison With Macro Economic Factors;

7.1. Ophthalmology Drugs Market Size, Percentage Of GDP, Global; 7.2. Per Capita Average Ophthalmology Drugs Expenditure, Global;

8. Ophthalmology Drugs Market Comparison With Macro Economic Factors Across Countries;

8.1. Ophthalmology Drugs Market Size, Percentage Of GDP, By Country; 8.2. Per Capita Average Ophthalmology Drugs Expenditure, By Country;

9. Ophthalmology Drugs Market Comparison With Industry Metrics;

9.1. Global Number Of Pharmacists, 2016, By Country; 9.2. Global Ophthalmology Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country; 9.3. Global Number Of Pharma Enterprises, 2016, By Country; 9.4. Global Ophthalmology Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country; 9.5. Global Average Spending On R&D/Product Development, 2016, By Country; 9.6. Global Ophthalmology Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country; 9.7. Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.8. Global Ophthalmology Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.9. Prevalent Cases Of Glaucoma, 2014, By Country;

10. Asia-Pacific Ophthalmology Drugs Market;

10.1.1. Asia-Pacific Ophthalmology Drugs Market Overview; 10.1.2. Asia-Pacific Ophthalmology Drugs Historic Market, 2012-2016; 10.1.3. Asia-Pacific Ophthalmology Drugs Forecast Market, 2016-2020; 10.1.4. Asia-Pacific Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 10.2. Asia-Pacific Ophthalmology Drugs Market: Country Analysis; 10.3. China Ophthalmology Drugs Market; 10.3.1. China Ophthalmology Drugs Market Overview; 10.3.2. China Ophthalmology Drugs Historic Market, 2012-2016; 10.3.3. China Ophthalmology Drugs Forecast Market, 2016-2020; 10.3.4. China Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 10.3.5. China Ophthalmology Drugs Percentage Of GDP, 2012-2020; 10.3.6. China Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020; 10.4. India Ophthalmology Drugs Market; 10.4.1. India Ophthalmology Drugs Market Overview; 10.4.2. India Ophthalmology Drugs Historic Market, 2012-2016; 10.4.3. India Ophthalmology Drugs Forecast Market, 2016-2020; 10.4.4. India Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 10.4.5. India Ophthalmology Drugs Percentage Of GDP, 2012-2020; 10.4.6. India Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020; 10.5. Japan Ophthalmology Drugs Market; 10.5.1. Japan Ophthalmology Drugs Market Overview; 10.5.2. Japan Ophthalmology Drugs Historic Market, 2012-2016; 10.5.3. Japan Ophthalmology Drugs Forecast Market, 2016-2020; 10.5.4. Japan Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 10.5.5. Japan Ophthalmology Drugs Percentage Of GDP, 2012-2020; 10.5.6. Japan Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020; 10.6. Australia Ophthalmology Drugs Market; 10.6.1. Australia Ophthalmology Drugs Historic Market, 2012-2016; 10.6.2. Australia Ophthalmology Drugs Forecast Market, 2016-2020; 10.6.3. Australia Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 10.6.4. Australia Ophthalmology Drugs Percentage Of GDP, 2012-2020; 10.6.5. Australia Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020;

11. Western Europe Ophthalmology Drugs Market;

11.1.1. Western Europe Ophthalmology Drugs Market Overview; 11.1.2. Western Europe Ophthalmology Drugs Historic Market, 2012-2016; 11.1.3. Western Europe Ophthalmology Drugs Forecast Market, 2016-2020; 11.1.4. Western Europe Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 11.2. Western Europe Ophthalmology Drugs Market: Country Analysis; 11.3. UK Ophthalmology Drugs Market; 11.3.1. UK Ophthalmology Drugs Market Overview; 11.3.2. UK Ophthalmology Drugs Historic Market, 2012-2016; 11.3.3. UK Ophthalmology Drugs Forecast Market, 2016-2020; 11.3.4. UK Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 11.3.5. UK Ophthalmology Drugs Percentage Of GDP, 2012-2020; 11.3.6. UK Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020; 11.4. Germany Ophthalmology Drugs Market; 11.4.1. Germany Ophthalmology Drugs Historic Market, 2012-2016; 11.4.2. Germany Ophthalmology Drugs Forecast Market, 2016-2020; 11.4.3. Germany Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 11.4.4 Germany Ophthalmology Drugs Percentage Of GDP, 2012-2020; 11.4.5 Germany Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020; 11.5 France Ophthalmology Drugs Market; 11.5.1 France Ophthalmology Drugs Historic Market, 2012-2016; 11.5.2 France Ophthalmology Drugs Forecast Market, 2016-2020; 11.5.3 France Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 11.5.4 France Ophthalmology Drugs Percentage Of GDP, 2012-2020; 11.5.5 France Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020; 11.6. Italy Ophthalmology Drugs Market; 11.6.1. Italy Ophthalmology Drugs Historic Market, 2012-2016; 11.6.2. Italy Ophthalmology Drugs Forecast Market, 2016-2020; 11.6.3. Italy Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 11.6.4. Italy Ophthalmology Drugs Percentage Of GDP, 2012-2020; 11.6.5. Italy Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020; 11.7. Spain Ophthalmology Drugs Market; 11.7.1. Spain Ophthalmology Drugs Historic Market, 2012-2016; 11.7.2. Spain Ophthalmology Drugs Forecast Market, 2016-2020; 11.7.3. Spain Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 11.7.4. Spain Ophthalmology Drugs Percentage Of GDP, 2012-2020; 11.7.5. Spain Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020;

12. Eastern Europe Ophthalmology Drugs Market;

12.1.1. Eastern Europe Ophthalmology Drugs Market Overview; 12.1.2. Eastern Europe Ophthalmology Drugs Historic Market, 2012-2016; 12.1.3. Eastern Europe Ophthalmology Drugs Forecast Market, 2016-2020; 12.1.4 Eastern Europe Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 12.2. Eastern Europe Ophthalmology Drugs Market: Country Analysis; 12.3. Russia Ophthalmology Drugs Market; 12.3.1. Russia Ophthalmology Drugs Historic Market, 2012-2016; 12.3.2. Russia Ophthalmology Drugs Forecast Market, 2016-2020; 12.3.3. Russia Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 12.3.4. Russia Ophthalmology Drugs Percentage Of GDP, 2012-2020; 12.3.5. Russia Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020;

13. North America Ophthalmology Drugs Market;

13.1.1. North America Ophthalmology Drugs Market Overview; 13.1.2. North America Ophthalmology Drugs Historic Market, 2012-2016; 13.1.3. North America Ophthalmology Drugs Forecast Market, 2016-2020; 13.1.4. North America Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 13.2. North America Ophthalmology Drugs Market: Country Analysis; 13.3. USA Ophthalmology Drugs Market; 13.3.1. USA Ophthalmology Drugs Historic Market, 2012-2016; 13.3.2. USA Ophthalmology Drugs Forecast Market, 2016-2020; 13.3.3 USA Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 13.3.4. USA Ophthalmology Drugs Percentage Of GDP, 2012-2020; 13.3.5. USA Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020;

14. South America Ophthalmology Drugs Market;

14.1.1. South America Ophthalmology Drugs Market Overview; 14.1.2. South America Ophthalmology Drugs Historic Market, 2012-2016; 14.1.3. South America Ophthalmology Drugs Forecast Market, 2016-2020; 14.1.4. South America Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 14.2. South America Ophthalmology Drugs Market: Country Analysis; 14.3. Brazil Ophthalmology Drugs Market; 14.3.1. Brazil Ophthalmology Drugs Historic Market, 2012-2016; 14.3.2. Brazil Ophthalmology Drugs Forecast Market, 2016-2020; 14.3.3. Brazil Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy); 14.3.4. Brazil Ophthalmology Drugs Percentage Of GDP, 2012-2020; 14.3.5. Brazil Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020;

15. Middle East Ophthalmology Drugs Market;

15.1.1. Middle East Ophthalmology Drugs Market Overview; 15.1.2. Middle East Ophthalmology Drugs Historic Market, 2012-2016; 15.1.3. Middle East Ophthalmology Drugs Forecast Market, 2016-2020; 15.1.4. Middle East Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy);

16. Africa Ophthalmology Drugs Market;

16.1.1. Africa Ophthalmology Drugs Market Overview; 16.1.2. Africa Ophthalmology Drugs Historic Market, 2012-2016; 16.1.3. Africa Ophthalmology Drugs Forecast Market, 2016-2020; 16.1.4. Africa Ophthalmology Drugs Market, 2016, By Segment; 16.1.4. Africa Ophthalmology Drugs Market, 2016, By Segment; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy);

17. Ophthalmology Drugs Market Competitive Landscape;

17.1. Company Profiles; 17.2. Novartis Ag; 17.2.1. Overview; 17.2.2. Products And Services; 17.2.3. Strategy; 17.2.4. Financial Performance; 17.3. Regeneron; 17.3.1. Overview; 17.3.2. Products And Services; 17.3.3. Strategy; 17.3.4. Financial Performance; 17.4. Allergan; 17.4.1. Overview; 17.4.2. Products And Services; 17.4.3. Strategy; 17.4.4. Financial Performance; 17.5. F. Hoffmann-La Roche Ltd; 17.5.1. Overview; 17.5.2. Products And Services; 17.5.3. Strategy; 17.5.4. Financial Performance; 17.6. Pfizer Inc.; 17.6.1. Overview; 17.6.2. Products And Services; 17.6.3. Strategy; 17.6.4. Financial Performance;

18. Key Mergers And Acquisitions In The Ophthalmology Drugs Market;

19. Market Background: Pharmaceutical Drugs Market;

19.1.1. Pharmaceutical Drugs Market Characteristics; 19.1.2. Pharmaceutical Drugs Market Historic Growth; 19.1.2.1. Drivers Of The Market; 19.1.2.2. Restraints Of The Market; 19.1.3. Pharmaceutical Drugs Market Forecast Growth; 19.1.3.1. Drivers Of The Market; 19.1.3.2. Restraints Of The Market; 19.1.4. Pharmaceutical Drugs Trends And Strategies; 19.2. Pharmaceutical Drugs Market Regional And Country Analysis; 19.2.1. Global Pharmaceutical Drugs Market, 2016, By Region; 19.2.2. Global Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Region; 19.2.3. Pharmaceutical Drugs Market, 2016, By Country; 19.2.4. Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Country; 19.2.5. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Segment; 19.2.6. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Country And Segment; 19.3. Global Pharmaceutical Drugs Market Comparison With Macro Economic Factors; 19.3.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, Global; 19.3.2. Per Capita Average Pharmaceutical Drugs Expenditure, Global; 19.4. Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries; 19.4.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country; 19.4.2. Per Capita Average Pharmaceutical Drugs Expenditure, By Country; 19.5. Key Mergers And Acquisitions In The Pharmaceutical Drugs Market;

20. Pharmaceuticals Industry Financial Margins;

21. Appendix;

21.1. NAICS Definitions Of Industry Covered In This Report; 21.2. Abbreviations; 21.3. Currencies; 21.4. Research Inquiries; 21.5. The Business Research Company; 21.6. Copyright And Disclaimer


List Of Figure

Table 1: Global Ophthalmology Drugs Historic Market Growth

Table 2: Global Ophthalmology Drugs Forecast Market Growth

Table 3: Ophthalmology Drugs Market Segmentation

Table 4: Global Ophthalmology Drugs Market, 2016, By Segment

Table 5: Global Ophthalmology Drugs Market, 2012-2020, Historic And Forecast, By Segment

Table 6: Global Ophthalmology Drugs Market, 2016, By Region

Table 7: Global Ophthalmology Drugs Market, 2012-2020, Historic And Forecast, By Region

Table 8: Ophthalmology Drugs Market, 2016, By Country

Table 9: Ophthalmology Drugs Market, 2012-2020, Historic And Forecast, By Country

Table 10: Global Pharmaceutical Market Segments, 2016, By Region

Table 11: Global Pharmaceutical Drugs Market Segments, 2016, By Region

Table 12: Global Pharmaceutical Market Segments, 2016, By Country

Table 13: Global Pharmaceutical Drugs Market Segments, 2016, By Country

Table 14: Ophthalmology Drugs Market Size, Percentage Of GDP, Global

Table 15: Per Capita Average Ophthalmology Drugs Expenditure, Global

Table 16: Ophthalmology Drugs Market Comparison With Macro Economic Factors Across Countries

Table 17: Ophthalmology Drugs Market Size, Percentage Of GDP, By Country

Table 18: Per Capita Average Ophthalmology Drugs Expenditure, By Country

Table 19: Global Number Of Pharmacists, 2016, By Country

Table 20: Global Ophthalmology Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country

Table 21: Global Number Of Pharma Enterprises, 2016, By Country

Table 22: Global Ophthalmology Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country

Table 23: Global Average Spending On R&D/Product Development, 2016, By Country

Table 24: Global Ophthalmology Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country

Table 25: Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country

Table 26: Global Ophthalmology Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country

Table 27: Prevalent Cases Of Glaucoma, 2014, By Country

Table 28: Asia-Pacific Ophthalmology Drugs Historic Market, 2012-2016

Table 29: Asia-Pacific Ophthalmology Drugs Forecast Market, 2016-2020

Table 30: Asia-Pacific Ophthalmology Drugs Market, 2016, By Segment

Table 31: China Ophthalmology Drugs Historic Market, 2012-2016

Table 32: China Ophthalmology Drugs Forecast Market, 2016-2020

Table 33: China Ophthalmology Drugs Market, 2016, By Segment

Table 34: China Ophthalmology Drugs Percentage Of GDP, 2012-2020

Table 35: China Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020

Table 36: India Ophthalmology Drugs Historic Market, 2012-2016

Table 37: India Ophthalmology Drugs Forecast Market, 2016-2020

Table 38: India Ophthalmology Drugs Market, 2016, By Segment

Table 39: India Ophthalmology Drugs Percentage Of GDP, 2012-2020

Table 40: India Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020

Table 41: Japan Ophthalmology Drugs Historic Market, 2012-2016

Table 42: Japan Ophthalmology Drugs Forecast Market, 2016-2020

Table 43: Japan Ophthalmology Drugs Market, 2016, By Segment

Table 44: Japan Ophthalmology Drugs Percentage Of GDP, 2012-2020

Table 45: Japan Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020

Table 46: Australia Ophthalmology Drugs Historic Market, 2012-2016

Table 47: Australia Ophthalmology Drugs Forecast Market, 2016-2020

Table 48: Australia Ophthalmology Drugs Market, 2016, By Segment

Table 49: Australia Ophthalmology Drugs Percentage Of GDP, 2012-2020

Table 50: Australia Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020

Table 51: Western Europe Ophthalmology Drugs Historic Market, 2012-2016

Table 52: Western Europe Ophthalmology Drugs Forecast Market, 2016-2020

Table 53: Western Europe Ophthalmology Drugs Market, 2016, By Segment

Table 54: UK Ophthalmology Drugs Historic Market, 2012-2016

Table 55: UK Ophthalmology Drugs Forecast Market, 2016-2020

Table 56: UK Ophthalmology Drugs Market, 2016, By Segment

Table 57: UK Ophthalmology Drugs Percentage Of GDP, 2012-2020

Table 58: UK Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020

Table 59: Germany Ophthalmology Drugs Historic Market, 2012-2016

Table 60: Germany Ophthalmology Drugs Forecast Market, 2016-2020

Table 61: Germany Ophthalmology Drugs Market, 2016, By Segment

Table 62: Germany Ophthalmology Drugs Percentage Of GDP, 2012-2020

Table 63: Germany Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020

Table 64: France Ophthalmology Drugs Historic Market, 2012-2016

Table 65: France Ophthalmology Drugs Forecast Market, 2016-2020

Table 66: France Ophthalmology Drugs Market, 2016, By Segment

Table 67: France Ophthalmology Drugs Percentage Of GDP, 2012-2020

Table 68: France Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020

Table 69: Italy Ophthalmology Drugs Historic Market, 2012-2016

Table 70: Italy Ophthalmology Drugs Forecast Market, 2016-2020

Table 71: Italy Ophthalmology Drugs Market, 2016, By Segment

Table 72: Italy Ophthalmology Drugs Percentage Of GDP, 2012-2020

Table 73: Italy Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020

Table 74: Spain Ophthalmology Drugs Historic Market, 2012-2016

Table 75: Spain Ophthalmology Drugs Forecast Market, 2016-2020

Table 76: Spain Ophthalmology Drugs Market, 2016, By Segment

Table 77: Spain Ophthalmology Drugs Percentage Of GDP, 2012-2020

Table 78: Spain Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020

Table 79: Eastern Europe Ophthalmology Drugs Historic Market, 2012-2016

Table 80: Eastern Europe Ophthalmology Drugs Forecast Market, 2016-2020

Table 81: Eastern Europe Ophthalmology Drugs Market, 2016, By Segment

Table 82: Russia Ophthalmology Drugs Historic Market, 2012-2016

Table 83: Russia Ophthalmology Drugs Forecast Market, 2016-2020

Table 84: Russia Ophthalmology Drugs Market, 2016, By Segment

Table 85: Russia Ophthalmology Drugs Percentage Of GDP, 2012-2020

Table 86: Russia Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020

Table 87: North America Ophthalmology Drugs Historic Market, 2012-2016

Table 88: North America Ophthalmology Drugs Forecast Market, 2016-2020

Table 89: North America Ophthalmology Drugs Market, 2016, By Segment

Table 90: USA Ophthalmology Drugs Historic Market, 2012-2016

Table 91: USA Ophthalmology Drugs Forecast Market, 2016-2020

Table 92: USA Ophthalmology Drugs Market, 2016, By Segment

Table 93: USA Ophthalmology Drugs Percentage Of GDP, 2012-2020

Table 94: USA Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020

Table 95: South America Ophthalmology Drugs Historic Market, 2012-2016

Table 96: South America Ophthalmology Drugs Forecast Market, 2016-2020

Table 97: South America Ophthalmology Drugs Market, 2016, By Segment

Table 98: Brazil Ophthalmology Drugs Historic Market, 2012-2016

Table 99: Brazil Ophthalmology Drugs Forecast Market, 2016-2020

Table 100: Brazil Ophthalmology Drugs Market, 2016, By Segment

Table 101: Brazil Ophthalmology Drugs Percentage Of GDP, 2012-2020

Table 102: Brazil Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020

Table 103: Middle East Ophthalmology Drugs Historic Market, 2012-2016

Table 104: Middle East Ophthalmology Drugs Forecast Market, 2016-2020

Table 105: Middle East Ophthalmology Drugs Market, 2016, By Segment

Table 106: Africa Ophthalmology Drugs Historic Market, 2012-2016

Table 107: Africa Ophthalmology Drugs Forecast Market, 2016-2020

Table 108: Africa Ophthalmology Drugs Market, 2016, By Segment

Table 109: Novartis Ag Financial Performance

Table 110: Regeneron Financial Performance

Table 111: Allergan Financial Performance

Table 112: F. Hoffmann-La Roche Ltd Financial Performance

Table 113: Pfizer Inc. Financial Performance

Table 114: Pharmaceutical Drugs Market Historic Growth

Table 115: Pharmaceutical Drugs Market Forecast Growth

Table 116: Global Pharmaceutical Drugs Market, 2016, By Region

Table 117: Global Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Region

Table 118: Pharmaceutical Drugs Market, 2016, By Country

Table 119: Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Country

Table 120: Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Segment

Table 121: Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Country And Segment

Table 122: Pharmaceutical Drugs Market Size, Percentage Of GDP, Global

Table 123: Per Capita Average Pharmaceutical Drugs Expenditure, Global

Table 124: Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries

Table 125: Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country

Table 126: Per Capita Average Pharmaceutical Drugs Expenditure, By Country

Table 127: Pharmaceuticals Industry Financial Margins


List Of Table

Figure 1: Global Ophthalmology Drugs Historic Market Growth

Figure 2: Global Ophthalmology Drugs Forecast Market Growth

Figure 3: Ophthalmology Drugs Market Segmentation

Figure 4: Global Ophthalmology Drugs Market, 2016, By Segment

Figure 5: Global Ophthalmology Drugs Market, 2012-2020, Historic And Forecast, By Segment

Figure 6: Global Ophthalmology Drugs Market, 2016, By Region

Figure 7: Global Ophthalmology Drugs Market, 2012-2020, Historic And Forecast, By Region

Figure 8: Ophthalmology Drugs Market, 2016, By Country

Figure 9: Ophthalmology Drugs Market, 2012-2020, Historic And Forecast, By Country

Figure 10: Global Pharmaceutical Market Segments, 2016, By Region

Figure 11: Global Pharmaceutical Drugs Market Segments, 2016, By Region

Figure 12: Global Pharmaceutical Market Segments, 2016, By Country

Figure 13: Global Pharmaceutical Drugs Market Segments, 2016, By Country

Figure 14: Ophthalmology Drugs Market Size, Percentage Of GDP, Global

Figure 15: Per Capita Average Ophthalmology Drugs Expenditure, Global

Figure 16: Ophthalmology Drugs Market Comparison With Macro Economic Factors Across Countries

Figure 17: Ophthalmology Drugs Market Size, Percentage Of GDP, By Country

Figure 18: Per Capita Average Ophthalmology Drugs Expenditure, By Country

Figure 19: Global Number Of Pharmacists, 2016, By Country

Figure 20: Global Ophthalmology Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country

Figure 21: Global Number Of Pharma Enterprises, 2016, By Country

Figure 22: Global Ophthalmology Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country

Figure 23: Global Average Spending On R&D/Product Development, 2016, By Country

Figure 24: Global Ophthalmology Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country

Figure 25: Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country

Figure 26: Global Ophthalmology Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country

Figure 27: Prevalent Cases Of Glaucoma, 2014, By Country

Figure 28: Asia-Pacific Ophthalmology Drugs Historic Market, 2012-2016

Figure 29: Asia-Pacific Ophthalmology Drugs Forecast Market, 2016-2020

Figure 30: Asia-Pacific Ophthalmology Drugs Market, 2016, By Segment

Figure 31: China Ophthalmology Drugs Historic Market, 2012-2016

Figure 32: China Ophthalmology Drugs Forecast Market, 2016-2020

Figure 33: China Ophthalmology Drugs Market, 2016, By Segment

Figure 34: China Ophthalmology Drugs Percentage Of GDP, 2012-2020

Figure 35: China Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020

Figure 36: India Ophthalmology Drugs Historic Market, 2012-2016

Figure 37: India Ophthalmology Drugs Forecast Market, 2016-2020

Figure 38: India Ophthalmology Drugs Market, 2016, By Segment

Figure 39: India Ophthalmology Drugs Percentage Of GDP, 2012-2020

Figure 40: India Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020

Figure 41: Japan Ophthalmology Drugs Historic Market, 2012-2016

Figure 42: Japan Ophthalmology Drugs Forecast Market, 2016-2020

Figure 43: Japan Ophthalmology Drugs Market, 2016, By Segment

Figure 44: Japan Ophthalmology Drugs Percentage Of GDP, 2012-2020

Figure 45: Japan Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020

Figure 46: Australia Ophthalmology Drugs Historic Market, 2012-2016

Figure 47: Australia Ophthalmology Drugs Forecast Market, 2016-2020

Figure 48: Australia Ophthalmology Drugs Market, 2016, By Segment

Figure 49: Australia Ophthalmology Drugs Percentage Of GDP, 2012-2020

Figure 50: Australia Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020

Figure 51: Western Europe Ophthalmology Drugs Historic Market, 2012-2016

Figure 52: Western Europe Ophthalmology Drugs Forecast Market, 2016-2020

Figure 53: Western Europe Ophthalmology Drugs Market, 2016, By Segment

Figure 54: UK Ophthalmology Drugs Historic Market, 2012-2016

Figure 55: UK Ophthalmology Drugs Forecast Market, 2016-2020

Figure 56: UK Ophthalmology Drugs Market, 2016, By Segment

Figure 57: UK Ophthalmology Drugs Percentage Of GDP, 2012-2020

Figure 58: UK Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020

Figure 59: Germany Ophthalmology Drugs Historic Market, 2012-2016

Figure 60: Germany Ophthalmology Drugs Forecast Market, 2016-2020

Figure 61: Germany Ophthalmology Drugs Market, 2016, By Segment

Figure 62: Germany Ophthalmology Drugs Percentage Of GDP, 2012-2020

Figure 63: Germany Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020

Figure 64: France Ophthalmology Drugs Historic Market, 2012-2016

Figure 65: France Ophthalmology Drugs Forecast Market, 2016-2020

Figure 66: France Ophthalmology Drugs Market, 2016, By Segment

Figure 67: France Ophthalmology Drugs Percentage Of GDP, 2012-2020

Figure 68: France Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020

Figure 69: Italy Ophthalmology Drugs Historic Market, 2012-2016

Figure 70: Italy Ophthalmology Drugs Forecast Market, 2016-2020

Figure 71: Italy Ophthalmology Drugs Market, 2016, By Segment

Figure 72: Italy Ophthalmology Drugs Percentage Of GDP, 2012-2020

Figure 73: Italy Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020

Figure 74: Spain Ophthalmology Drugs Historic Market, 2012-2016

Figure 75: Spain Ophthalmology Drugs Forecast Market, 2016-2020

Figure 76: Spain Ophthalmology Drugs Market, 2016, By Segment

Figure 77: Spain Ophthalmology Drugs Percentage Of GDP, 2012-2020

Figure 78: Spain Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020

Figure 79: Eastern Europe Ophthalmology Drugs Historic Market, 2012-2016

Figure 80: Eastern Europe Ophthalmology Drugs Forecast Market, 2016-2020

Figure 81: Eastern Europe Ophthalmology Drugs Market, 2016, By Segment

Figure 82: Russia Ophthalmology Drugs Historic Market, 2012-2016

Figure 83: Russia Ophthalmology Drugs Forecast Market, 2016-2020

Figure 84: Russia Ophthalmology Drugs Market, 2016, By Segment

Figure 85: Russia Ophthalmology Drugs Percentage Of GDP, 2012-2020

Figure 86: Russia Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020

Figure 87: North America Ophthalmology Drugs Historic Market, 2012-2016

Figure 88: North America Ophthalmology Drugs Forecast Market, 2016-2020

Figure 89: North America Ophthalmology Drugs Market, 2016, By Segment

Figure 90: USA Ophthalmology Drugs Historic Market, 2012-2016

Figure 91: USA Ophthalmology Drugs Forecast Market, 2016-2020

Figure 92: USA Ophthalmology Drugs Market, 2016, By Segment

Figure 93: USA Ophthalmology Drugs Percentage Of GDP, 2012-2020

Figure 94: USA Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020

Figure 95: South America Ophthalmology Drugs Historic Market, 2012-2016

Figure 96: South America Ophthalmology Drugs Forecast Market, 2016-2020

Figure 97: South America Ophthalmology Drugs Market, 2016, By Segment

Figure 98: Brazil Ophthalmology Drugs Historic Market, 2012-2016

Figure 99: Brazil Ophthalmology Drugs Forecast Market, 2016-2020

Figure 100: Brazil Ophthalmology Drugs Market, 2016, By Segment

Figure 101: Brazil Ophthalmology Drugs Percentage Of GDP, 2012-2020

Figure 102: Brazil Per Capita Average Ophthalmology Drugs Expenditure, 2012-2020

Figure 103: Middle East Ophthalmology Drugs Historic Market, 2012-2016

Figure 104: Middle East Ophthalmology Drugs Forecast Market, 2016-2020

Figure 105: Middle East Ophthalmology Drugs Market, 2016, By Segment

Figure 106: Africa Ophthalmology Drugs Historic Market, 2012-2016

Figure 107: Africa Ophthalmology Drugs Forecast Market, 2016-2020

Figure 108: Africa Ophthalmology Drugs Market, 2016, By Segment

Figure 109: Novartis Ag Financial Performance

Figure 110: Regeneron Financial Performance

Figure 111: Allergan Financial Performance

Figure 112: F. Hoffmann-La Roche Ltd Financial Performance

Figure 113: Pfizer Inc. Financial Performance

Figure 114: Pharmaceutical Drugs Market Historic Growth

Figure 115: Pharmaceutical Drugs Market Forecast Growth

Figure 116: Global Pharmaceutical Drugs Market, 2016, By Region

Figure 117: Global Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Region

Figure 118: Pharmaceutical Drugs Market, 2016, By Country

Figure 119: Pharmaceutical Drugs Market, 2012-2020, Historic And Forecast, By Country

Figure 120: Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Segment

Figure 121: Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Country And Segment

Figure 122: Pharmaceutical Drugs Market Size, Percentage Of GDP, Global

Figure 123: Per Capita Average Pharmaceutical Drugs Expenditure, Global

Figure 124: Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries

Figure 125: Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country

Figure 126: Per Capita Average Pharmaceutical Drugs Expenditure, By Country

Figure 127: Pharmaceuticals Industry Financial Margins

  • Single User License (for access by one person)
  • Site License (for access of one office location of a company)
  • Corporate License (allow access by all staff of the company)
To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Antiglaucoma Drugs, Dry Eye Medication, Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy)


Companies

Novartis AG, Regeneron, Allergan, F. Hoffmann-La Roche Ltd, and Pfizer Inc.